Last updated on September 2020

Phase 1 Study of SQ3370 in Patients With Advanced Solid Tumors

Brief description of study

The purpose of this study is to evaluate the safety, tolerability, and preliminary efficacy of SQ3370 in patients with cancer (solid tumors).

Clinical Study Identifier: NCT04106492

Find a site near you

Start Over

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.